410 related articles for article (PubMed ID: 23390616)
1. Regulation of the Yersinia type III secretion system: traffic control.
Dewoody RS; Merritt PM; Marketon MM
Front Cell Infect Microbiol; 2013; 3():4. PubMed ID: 23390616
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
Marenne MN; Journet L; Mota LJ; Cornelis GR
Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
[TBL] [Abstract][Full Text] [Related]
4. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
5. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
Harmon DE; Murphy JL; Davis AJ; Mecsas J
J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
[TBL] [Abstract][Full Text] [Related]
6. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
[TBL] [Abstract][Full Text] [Related]
7. Piericidin A1 Blocks
Morgan JM; Duncan MC; Johnson KS; Diepold A; Lam H; Dupzyk AJ; Martin LR; Wong WR; Armitage JP; Linington RG; Auerbuch V
mSphere; 2017; 2(1):. PubMed ID: 28217742
[TBL] [Abstract][Full Text] [Related]
8. LcrV mutants that abolish Yersinia type III injectisome function.
Ligtenberg KG; Miller NC; Mitchell A; Plano GV; Schneewind O
J Bacteriol; 2013 Feb; 195(4):777-87. PubMed ID: 23222719
[TBL] [Abstract][Full Text] [Related]
9. The Yersinia Ysc-Yop virulence apparatus.
Cornelis GR
Int J Med Microbiol; 2002 Feb; 291(6-7):455-62. PubMed ID: 11890544
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins.
Tejeda-Dominguez F; Huerta-Cantillo J; Chavez-Dueñas L; Navarro-Garcia F
mBio; 2017 Mar; 8(2):. PubMed ID: 28351918
[TBL] [Abstract][Full Text] [Related]
11. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
[TBL] [Abstract][Full Text] [Related]
12. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
[TBL] [Abstract][Full Text] [Related]
13. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
15. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
Adams W; Morgan J; Kwuan L; Auerbuch V
Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
[TBL] [Abstract][Full Text] [Related]
16. YopK regulates the Yersinia pestis type III secretion system from within host cells.
Dewoody R; Merritt PM; Houppert AS; Marketon MM
Mol Microbiol; 2011 Mar; 79(6):1445-61. PubMed ID: 21205017
[TBL] [Abstract][Full Text] [Related]
17. Evidence for targeting of Yop effectors by the chromosomally encoded Ysa type III secretion system of Yersinia enterocolitica.
Young BM; Young GM
J Bacteriol; 2002 Oct; 184(20):5563-71. PubMed ID: 12270813
[TBL] [Abstract][Full Text] [Related]
18. Probing the cellular effects of bacterial effector proteins with the Yersinia toolbox.
Wölke S; Heesemann J
Future Microbiol; 2012 Apr; 7(4):449-56. PubMed ID: 22439722
[TBL] [Abstract][Full Text] [Related]
19. The gatekeeper of Yersinia type III secretion is under RNA thermometer control.
Pienkoß S; Javadi S; Chaoprasid P; Nolte T; Twittenhoff C; Dersch P; Narberhaus F
PLoS Pathog; 2021 Nov; 17(11):e1009650. PubMed ID: 34767606
[TBL] [Abstract][Full Text] [Related]
20. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.
Mueller CA; Broz P; Müller SA; Ringler P; Erne-Brand F; Sorg I; Kuhn M; Engel A; Cornelis GR
Science; 2005 Oct; 310(5748):674-6. PubMed ID: 16254184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
